MICHELLE RENE MOREL
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant IRON MOUNTAIN, MI NPI 1437239258
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant MI Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$6,343.75
- Category: General Payments
- Program years: PY2021–2024
- Record count: 321
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,182.01 across 57 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,083.01 | 56 |
| Education | $99.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $212.48 | 10 |
| Daiichi Sankyo Inc. | $82.39 | 4 |
| PFIZER INC. | $78.72 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $77.06 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $77.03 | 3 |
| Merck Sharp & Dohme Corporation | $71.19 | 3 |
| Alexion Pharmaceuticals, Inc. | $67.65 | 3 |
| Genentech USA, Inc. | $53.90 | 3 |
| Lilly USA, LLC | $48.77 | 2 |
| Incyte Corporation | $48.13 | 3 |
| Astellas Pharma US Inc | $43.61 | 2 |
| Blueprint Medicines Corporation | $39.35 | 2 |
| GENZYME CORPORATION | $28.35 | 1 |
| Acerta Pharma LLC | $27.69 | 1 |
| ABBVIE INC. | $26.24 | 1 |
| Celgene Corporation | $23.78 | 1 |
| EISAI INC. | $21.40 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.47 | 1 |
| AVEO Pharmaceuticals, Inc. | $18.61 | 1 |
| TerSera Therapeutics LLC | $18.47 | 1 |
| Gilead Sciences, Inc. | $17.68 | 1 |
| Sumitomo Pharma America, Inc. | $17.53 | 1 |
| GlaxoSmithKline, LLC. | $16.70 | 1 |
| ARRAY BIOPHARMA INC | $15.53 | 1 |
| Stemline Therapeutics Inc. | $15.31 | 1 |
| JAZZ PHARMACEUTICALS INC. | $14.97 | 1 |
By program year
Records — PY2024 (57)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.